BRPI0411623A - forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo - Google Patents
forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativoInfo
- Publication number
- BRPI0411623A BRPI0411623A BRPI0411623-2A BRPI0411623A BRPI0411623A BR PI0411623 A BRPI0411623 A BR PI0411623A BR PI0411623 A BRPI0411623 A BR PI0411623A BR PI0411623 A BRPI0411623 A BR PI0411623A
- Authority
- BR
- Brazil
- Prior art keywords
- sporopolenin
- spore
- functionalized
- exine
- coating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
"FORMA DE DOSAGEM FARMACêUTICA OU DIETéTICA, ESPOROPOLENINA, MéTODO PARA A FORMAçãO DE UMA ESPOROPOLENINA FUNCIONALIZADA COM AMINA PRIMARIA OU UM OUTRO REVESTIMENTO DE EXINA, MéTODO PARA A FORMAçãO DE UMA ESPOROPOLENINA FUNCIONALIZADA COM POLIAMINO OU UM OUTRO REVESTIMENTO DE EXINA DE UM ESPORO , MéTODO PARA A OBTENçãO DE UMA ESPOROPOLENINA FUNCIONALIZADA COM AMINOáCIDO OU UM OUTRO REVESTIMENTO DE EXINA DE UM ESPORO, ESPOROPOLENINA FUNCIONALIZADA OU UM OUTRO REVESTIMENTO DE EXINA DE UM ESPORO, FORMA DE DOSAGEM DIETéTICA OU FLAVORIZANTE, MéTODO DE PREENCHIMENTO DE REVESTIMENTOS DE EXINA DE ESPOROS, USO DA FORMA DE DOSAGEM E MéTODO DE APLICAçãO ORAL DE UM INGREDIENTE ATIVO". Trata-se de uma forma de dosagem farmacêutica ou dietética que compreende uma quantidade eficaz de uma substância ativa química ou fisicamente ligada a um suporte, que compreende esporopolenina, ou um outro revestimento de exina similar de esporos, de uma planta de fungo, opcionalmente com outros excipientes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0315019A GB0315019D0 (en) | 2003-06-27 | 2003-06-27 | Dosage form |
GB0411047A GB0411047D0 (en) | 2004-05-18 | 2004-05-18 | Dosage form |
PCT/GB2004/002775 WO2005000280A2 (en) | 2003-06-27 | 2004-06-28 | Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0411623A true BRPI0411623A (pt) | 2006-08-08 |
Family
ID=33554168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0411623-2A BRPI0411623A (pt) | 2003-06-27 | 2004-06-28 | forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1638538B1 (pt) |
JP (1) | JP5059402B2 (pt) |
KR (1) | KR101190766B1 (pt) |
AU (1) | AU2004251496B2 (pt) |
BR (1) | BRPI0411623A (pt) |
CA (1) | CA2530645C (pt) |
MX (1) | MXPA05013965A (pt) |
MY (1) | MY149933A (pt) |
WO (1) | WO2005000280A2 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7608270B2 (en) | 2003-06-27 | 2009-10-27 | University Of Hull | Dosage form |
GB0427520D0 (en) * | 2004-12-16 | 2005-01-19 | Univ Hull | Magnetic resonance contrast media |
DE102005016714A1 (de) * | 2005-04-11 | 2006-10-12 | Maack, Andreas, Dipl.-Chem.Dr. | Verwendung von Sporopollenin und/oder deren Derivaten als Bestandteil von Arzneimitteln, Medizinalprodukten und Nahrungsergänzungsmitteln |
US8784851B2 (en) | 2005-07-28 | 2014-07-22 | University Of Hull | Topical formulations containing sporopollenin |
GB0724550D0 (en) * | 2007-12-18 | 2008-01-30 | Univ Hull | Formulations |
GB0812513D0 (en) | 2008-07-09 | 2008-08-13 | Univ Hull | Delivery vehicle |
GB2488838A (en) * | 2011-03-11 | 2012-09-12 | Biomimetics Health Ind Ltd | A stable antimicrobial aqueous hypochlorous acid solution |
DE102012216190A1 (de) | 2012-09-12 | 2014-04-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Komposite und Beschichtungsstoffe mit in biologischem Hüllmaterial inkludierten Wirkstoffen |
EP3513805A1 (en) * | 2012-10-15 | 2019-07-24 | Texas Tech University System | Immunomodulation using spores and pollen grains |
EP3528856B1 (en) | 2016-10-18 | 2023-07-12 | Marquette University | Composite materials containing structural polymers and photoreactive nitric oxide releasing agents and uses thereof for wound dressings |
EP3581174A4 (en) | 2017-02-09 | 2020-12-30 | Universidade de Santiago de Compostela | PURIFIED POLLEN PARTICLES AND THEIR USE TO DELIVER NANOSYSTEMS |
US10913937B2 (en) * | 2017-04-17 | 2021-02-09 | Lafayette College | Degradation of sporopollenin |
WO2019113396A1 (en) * | 2017-12-08 | 2019-06-13 | President And Fellows Of Harvard College | Micro-and nanoneedles for plant and other cell penetration |
GB202102748D0 (en) | 2021-02-26 | 2021-04-14 | Botanical Solutions Ltd | Exine constructs |
WO2022180405A1 (en) | 2021-02-26 | 2022-09-01 | Sporomex Limited | Methods for the extraction of dispersible microcapsules |
EP4312996A1 (en) | 2021-03-26 | 2024-02-07 | Sporomex Limited | Methods for the extraction of dispersible microcapsules (immunocontraception) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59116208A (ja) * | 1982-12-24 | 1984-07-05 | Kobayashi Kooc:Kk | プレス状メイクアップ化粧料 |
JPS6359378A (ja) * | 1986-08-28 | 1988-03-15 | Kiteii:Kk | 物体の表面に主剤を固着させる剤及び方法 |
US5013552A (en) * | 1989-02-06 | 1991-05-07 | Samir Amer Moh | Modified pollen grains for delivering biologically active substances to plants and animals |
JP2970957B2 (ja) * | 1991-05-15 | 1999-11-02 | 株式会社グレイトチレン | 精製花粉栄養調整物 |
CN1105594A (zh) * | 1994-11-16 | 1995-07-26 | 潘自航 | 降癌灵丹 |
US6156330A (en) * | 1997-05-14 | 2000-12-05 | Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Sciences Ministry Of Agriculture, Forestry And Fisheries | Chitin beads, chitosan beads, process for preparing these beads, carrier comprising said beads, and process for preparing microsporidian spore |
DE19902724A1 (de) * | 1999-01-19 | 2000-07-27 | Dietmar Lerche | Mikrokapseln aus Sporopollenin, Verfahren zu ihrer Herstellung und Anwendung |
-
2004
- 2004-06-28 JP JP2006516482A patent/JP5059402B2/ja not_active Expired - Fee Related
- 2004-06-28 WO PCT/GB2004/002775 patent/WO2005000280A2/en active Application Filing
- 2004-06-28 CA CA2530645A patent/CA2530645C/en active Active
- 2004-06-28 KR KR1020057025138A patent/KR101190766B1/ko active IP Right Grant
- 2004-06-28 EP EP04743123.4A patent/EP1638538B1/en active Active
- 2004-06-28 MY MYPI20042537A patent/MY149933A/en unknown
- 2004-06-28 MX MXPA05013965A patent/MXPA05013965A/es active IP Right Grant
- 2004-06-28 AU AU2004251496A patent/AU2004251496B2/en not_active Ceased
- 2004-06-28 BR BRPI0411623-2A patent/BRPI0411623A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20060094848A (ko) | 2006-08-30 |
CA2530645A1 (en) | 2005-01-06 |
KR101190766B1 (ko) | 2012-10-12 |
CA2530645C (en) | 2013-05-07 |
JP2007520430A (ja) | 2007-07-26 |
EP1638538A2 (en) | 2006-03-29 |
WO2005000280A3 (en) | 2005-06-16 |
MXPA05013965A (es) | 2006-05-25 |
AU2004251496B2 (en) | 2009-10-01 |
WO2005000280A2 (en) | 2005-01-06 |
AU2004251496A1 (en) | 2005-01-06 |
EP1638538B1 (en) | 2018-02-14 |
JP5059402B2 (ja) | 2012-10-24 |
MY149933A (en) | 2013-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0411623A (pt) | forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo | |
HRP20060240T3 (en) | Intranasal formulation of rotigotine | |
BRPI0508125A (pt) | formulação de alcalóide, método para melhorar a eficácia de um alcalóide, uso do produto da reação de um ou mais alcalóides com um mais derivados de fosfato de um ou mais agentes de transferência de elétrons, junto com excipientes e composição farmacêutica | |
EA200501586A1 (ru) | Фармацевтические продукты | |
NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
EA200300999A1 (ru) | Хронотерапевтические дозированные формы | |
CY1107512T1 (el) | Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους | |
BRPI0412029A (pt) | formulações para microprojeções revestidas contendo contra-ìons não-voláteis | |
HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
BRPI0512756A (pt) | composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas | |
AR055319A1 (es) | Derivados de isoquinoleina, composiciones farmaceuticas y usos | |
CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
ECSP024341A (es) | Composiciones farmaceuticas | |
GB0323684D0 (en) | Improvements in or relating to organic compounds | |
NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
DK1345595T3 (da) | Ionstyrke-uafhængig farmaceutisk formulering med depotfrigivelse | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
EA200600603A1 (ru) | Оральная система доставки лекарственного препарата | |
ATE460934T1 (de) | Pharmazeutische zubereitungen von ciprofloxacin | |
DK1250125T3 (da) | Farmaceutiske præparater, som indeholder terbinafin | |
EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
SE0202365D0 (sv) | New formulation and use thereof | |
HRP20070081T5 (en) | Nasal pharmaceutical composition of piribedil | |
BR0115206A (pt) | Composições hidroliticamente instáveis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 9/50 , A61K 9/20 , A61K 47/48 , A23L 1/00 Ipc: A61K 47/48 (2006.01), A61K 9/20 (2006.01), A61K 9/ |
|
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A23P 10/30 (2016.01), A61K 9/20 (2006.01), A61K 9/ |